Mark Pruzanski


Intercept Pharmaceuticals Inc (ICPT) Moves Forward With OCA REGENERATE Trial; But Why Did Shares Slide 10%?

On May 19, Intercept Pharmaceuticals Inc (NASDAQ:ICPT) announced plans for an international Phase 3 trial of OCA in patients with NASH. Although this …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts